Leslie Trigg Sells 10,227 Shares of Outset Medical, Inc. (NASDAQ:OM) Stock

Outset Medical, Inc. (NASDAQ:OM - Get Free Report) CEO Leslie Trigg sold 10,227 shares of the firm's stock in a transaction that occurred on Tuesday, January 7th. The shares were sold at an average price of $1.29, for a total transaction of $13,192.83. Following the completion of the transaction, the chief executive officer now owns 894,624 shares in the company, valued at $1,154,064.96. The trade was a 1.13 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website.

Leslie Trigg also recently made the following trade(s):

• On Friday, November 15th, Leslie Trigg sold 5,645 shares of Outset Medical stock. The shares were sold at an average price of $0.80, for a total value of $4,516.00.

Outset Medical Stock Performance

OM traded down $0.17 during trading hours on Tuesday, hitting $1.10. 3,730,312 shares of the stock were exchanged, compared to its average volume of 3,236,809. The company has a debt-to-equity ratio of 4.12, a current ratio of 6.49 and a quick ratio of 5.04. Outset Medical, Inc. has a 12 month low of $0.44 and a 12 month high of $5.67. The stock has a 50-day simple moving average of $0.98 and a 200-day simple moving average of $1.50. The stock has a market cap of $57.80 million, a price-to-earnings ratio of -0.40 and a beta of 2.05.

Analyst Ratings Changes

Separately, Royal Bank of Canada reiterated a "sector perform" rating and issued a $3.00 price objective on shares of Outset Medical in a report on Tuesday.

Hedge Funds Weigh In On Outset Medical

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Millennium Management LLC raised its position in shares of Outset Medical by 58.8% during the 2nd quarter. Millennium Management LLC now owns 1,942,899 shares of the company's stock worth $7,480,000 after buying an additional 719,412 shares in the last quarter. Massachusetts Financial Services Co. MA boosted its stake in Outset Medical by 118.5% during the second quarter. Massachusetts Financial Services Co. MA now owns 1,538,859 shares of the company's stock valued at $5,925,000 after buying an additional 834,663 shares in the last quarter. GSA Capital Partners LLP grew its holdings in Outset Medical by 924.7% during the third quarter. GSA Capital Partners LLP now owns 1,111,612 shares of the company's stock worth $753,000 after acquiring an additional 1,003,135 shares during the period. Acadian Asset Management LLC boosted its position in shares of Outset Medical by 5.2% during the 2nd quarter. Acadian Asset Management LLC now owns 819,563 shares of the company's stock valued at $3,154,000 after purchasing an additional 40,321 shares in the last quarter. Finally, Marshall Wace LLP grew its position in Outset Medical by 487.8% in the second quarter. Marshall Wace LLP now owns 314,187 shares of the company's stock worth $1,210,000 after buying an additional 260,740 shares during the last quarter.

About Outset Medical

Outset Medical, Inc, a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.